Big drugmakers aren’t doing as big deals as they had, mostly doing less risky bolt-ons under $10 billion

3 weeks ago 17

1. Homepage
2. Health
3. Big drugmakers aren’t doing as big deals as they had, mostly doing less risky bolt-ons under $10 billion